Peer-reviewed evidence

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Reference Library, Resource Type, SAVIMS Media, SAVIMS Publications, Vaccine safety & adverse events, Vaccines, Viral illnesses

Restricted content

Suzanne | 28/07/2026 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Reference Library, Resource Type, SAVIMS Media, SAVIMS Publications, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Reference Library, Resource Type, SAVIMS Media, SAVIMS Publications, Vaccine safety & adverse events, Vaccines, Viral illnesses

Restricted content

Suzanne | 02/09/2025 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Reference Library, Resource Type, SAVIMS Media, SAVIMS Publications, Vaccine safety & adverse events, Vaccines, Viral illnesses

Covid-19 vaccines, Genetic vaccines, Peer-reviewed evidence, Vaccine safety & adverse events

Safety of J&J Ad26. COV2.S vaccine: Sisonke study

Herman Edeling | 30/04/2025 | Covid-19 vaccines, Genetic vaccines, Peer-reviewed evidence, Vaccine safety & adverse events

SisonkeTrialReport-J&J-3b-Safety-PlosMedicine Comments: BE WARY OF CONCLUSIONS IN HEADLINES AND ABSTRACTS. Reading the abstract of this J&J Covid-19 vaccine study among South African healthcare workers leaves one with a sense of trust and confidence. The authors claim “The single-dose Ad26.CoV2.S vaccine had an acceptable safety profile supporting the continued use of this vaccine in our setting.”

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Critical Review of COVID-19 Vaccines in Australia

Director | 11/02/2025 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Turni, C., & Lefringhausen, A. (2022). COVID-19 vaccines – An Australian review. Journal of Clinical & Experimental Immunology, 7(3), 491-508. Summary: This review evaluates COVID-19 mRNA vaccines from an Australian perspective, focusing on their safety and efficacy. The authors discuss initial promises versus actual outcomes, citing serious side effects—including deaths—from collected case reports. They

Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Treatment

Insights from JAHA 2017

Director | 11/02/2025 | Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Treatment

Reference: American Heart Association. (2017). Title of the article. Journal of the American Heart Association, 6. https://www.ahajournals.org Summary: The article published in the Journal of the American Heart Association (JAHA) in 2017 explores significant advancements in cardiovascular research. It discusses the role of genetics in heart disease, highlighting how specific genetic markers can predict susceptibility

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Evaluating the Pathophysiology of COVID-19 Vaccine Adverse Events

Director | 24/07/2024 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: du Preez, H. N., Lin, J., Maguire, G. E. M., Aldous, C., & Kruger, H. G. (2024). COVID-19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy. European Journal of Clinical Investigation, 00, e14296. https://doi.org/10.1111/eci.14296 Summary: This narrative review examines the pathophysiology of severe adverse events (AEs) associated with

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19 Vaccine Safety Signals: A Global Analysis

Director | 12/02/2024 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Faksova, K., Walsh, D., Jiang, Y., Griffin, J., Phillips, A., Gentile, A., … & Hviid, A. (2024). COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. https://doi.org/10.1016/j.vaccine.2024.01.100 Summary: This study evaluates the risk of adverse events following COVID-19 vaccination across

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19 Vaccines and Adverse Events: Insights from a Global Study

Director | 30/01/2024 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Faksova, K., Walsh, D., Jiang, Y., Griffin, J., Phillips, A., Gentile, A., Kwong, J.C., Macartney, K., Naus, M., Grange, Z., Escolano, S., Sepulveda, G., Shetty, A., Pillsbury, A., Sullivan, C., Naveed, Z., Janjua, N.Z., Giglio, N., Perälä, J., Nasreen, S., Gidding, H., Hovi, P., Vo, T., Cui, F., Deng, L., Cullen, L., Artama, M.,

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Critical Review of COVID-19 mRNA Vaccines: Safety and Efficacy Concerns

Director | 24/01/2024 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 mRNA vaccines: Lessons learned from the registrational trials and global vaccination campaign. Cureus, 16(1), e52876. https://doi.org/10.7759/cureus.52876 Summary: The article critically examines the safety and efficacy of COVID-19 mRNA vaccines, highlighting significant concerns regarding trial methodologies

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Impact of N1-Methylpseudouridine on mRNA Translation Fidelity

Director | 06/12/2023 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Mulroney, T. E., Pöyry, T., Yam-Puc, J. C., Rust, M., Harvey, R. F., Kalmar, L., Horner, E., Booth, L., Ferreira, A. P., Stoneley, M., Sawarkar, R., Mentzer, A. J., Lilley, K. S., Smales, C. M., von der Haar, T., Turtle, L., Dunachie, S., Klenerman, P., Thaventhiran, J. E. D., & Willis, A. E. (2023).